The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial "DISC"


Phase 2 Results N/A

Summary of Purpose

Numerous neuroprotectants have been effective when given prior to ischemic stroke in animals, yet they have all have failed when given after ischemic stroke in humans. A novel approach to ischemic neuroprotection is needed. Many patients who undergo cardiac, vascular, and neurosurgical procedures develop ischemic central nervous system (CNS) complications. These high risk surgeries present a unique...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 June 2012.

1 Jan 2008 27 Mar 2008 1 Jul 2010 1 Oct 2010 1 Jun 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Single Group Assignment


Not available